Extrait

The purpose of this trial is to demonstrate the efficacy and safety of everolimus in combination with reduced tacrolimus, compared to tacrolimus control, in living donor liver transplant recipients.

Critère d'inclusion

• Liver Transplantation

Pays

• Canada
• Egypt
• Germany
• India
• Italy
• Japan
• Korea, Republic of
• Russian Federation
• Saudi Arabia
• Singapore
• Taiwan, Province of China
• Turkey
• United States

Liens

• nct
• ictrp